VIKING GLOBAL INVESTORS LP - 12 Feb 2026 SCHEDULE 13D/A Report for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)

Filing Manager
VIKING GLOBAL INVESTORS LP
Reporting Manager
VIKING GLOBAL INVESTORS LP
Security
BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share
Symbol
BBIO
Shares outstanding
191,564,221 shares
Disclosed Ownership
13,026,367 shares
Ownership
6.8%
Form type
SCHEDULE 13D/A
Filing time
17 Feb 2026, 20:46:59 UTC
Date of event
12 Feb 2026
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
VIKING GLOBAL INVESTORS LP 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of VIKING GLOBAL INVESTORS LP (1)(2)(3) 0001103804
Viking Global Opportunities Parent GP LLC 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of Viking Global Opportunities Parent GP LLC (1)(2)(3) 0001886738
Viking Global Opportunities GP LLC 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of Viking Global Opportunities GP LLC (1)(2)(3) 0001629476
Viking Global Opportunities Portfolio GP LLC 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of Viking Global Opportunities Portfolio GP LLC (1)(2)(3) 0001629472
Viking Global Opportunities Illiquid Investments Sub-Master LP 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP (1)(2)(3) 0001629482
HALVORSEN OLE ANDREAS 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of HALVORSEN OLE ANDREAS (1) 0001133006
Ott David C. 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of Ott David C. (2) 0001621842
Shabet Rose Sharon 6.8% 13,026,367 0 13,026,367 /s/ Scott M. Hendler Scott M. Hendler on behalf of Shabet Rose Sharon (3) 0001711393